Posts Tagged ‘Genetics’
Seattle Genetics and Mill? Millennium report data? If Phase II registration pending initial positive Vedotin Brentuximab (SGN-35) if RecA? Da. . .
December 11th, 2010 | 
Author: Seattle Genetics and Millennium Report Positive Data from Phase II Trial of Brentuximab Vedotin (SGN-35) in Relapsed …
ORLANDO, Fla.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced positive data from a phase II clinical trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin is …
Read more on Business Wire
Related Blogs
- Spherix Phase 2 diabetes clinical trial determines minimum D …
- Seattle Genetics, Millennium Report Groundbreaking Results With …
- Seattle Genetics, Inc. (NASDAQ: SGEN) Given “Buy” Rating by …
- Reese Pharmaceutical Company Announces the Voluntary Nationwide …
- Phase II – www.basildawkins.com – oDesk | Freelance Jobs
Posted in Work From Home | 
Tags: Brentuximab, Data, Genetics, initial, Mill, Millennium, pending, phase, Positive, RecA, registration, Report, Seattle, SGN35, Vedotin | 
1 Comment »
Seattle Genetics est? having one? Antibody-m tape? Medicament conjugate? collaboration? n with Agensys, a subsidiary of Astellas
Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas
BOTHELL, Wash.—-Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc.
Read more on Business Wire via Yahoo! Finance
Related Blogs
Posted in Affiliate Programs |
Tags: Agensys, Antibodym, Astellas, Collaboration, conjugate, Genetics, having, Medicament, Seattle, subsidiary, tape |
1 Comment »
Seattle Genetics and Agensys, a subsidiary of Astellas Announce Opening of Phase I clinical trials ASG-fifth. . .
Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation of Phase I Clinical Trial of ASG-5ME for …
BOTHELL, Wash.—-Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer.
Read more on Business Wire via Yahoo! Finance
Related Blogs
- SiteGround Selects The Planet Server Cloud – Business Wire (press …
- Angelina Jolie scolds Maddox in Tokyo airport | HollywoodNews.com
- Seattle Genetics Inc. (SGEN) goes negative by breaking below …
- Pancreatic Cancer Drug: Seattle Genetics and Partner Agensys Start …
- More Information on Research and Clinical Trials « Autism Speaks …
Posted in Affiliate Programs |
Tags: Agensys, Announce, ASGfifth., Astellas, Clinical, Genetics, Opening, phase, Seattle, subsidiary, Trials |
No Comments »
Seattle Genetics and reprocessing Millennium positive report data Brentuximab Vedotin (SGN-35) in lymphoma
Seattle Genetics and Millennium Report Positive Data on Retreatment with Brentuximab Vedotin (SGN-35) in Lymphoma
Seattle Genetics, Inc. (Nasdaq:SGEN) and Millennium: The Takeda Oncology Company, …
Read more on Finanzen.net
Related Blogs
- Comprehensive Textbook of Genitourinary Oncology | Center …
- Seattle Genetics Inc. (SGEN) goes negative by breaking below …
- Seattle Genetics Inc. (SGEN) goes positive by breaking intraday …
- Is having Hodgkin's Lymphoma and Bone cancer at the same time …
- Disease Essentials – Oncology: Breast Cancer | Geo Blog
Posted in Affiliate Programs |
Tags: Brentuximab, Data, Genetics, lymphoma, Millennium, Positive, Report, reprocessing, Seattle, SGN35, Vedotin |
No Comments »
Seattle Genetics Reports First Quarter 2010 Financial Results
Seattle Genetics Reports First Quarter 2010 Financial Results
BOTHELL, Wash.—-Seattle Genetics, Inc. today reported financial results for the first quarter ended March 31, 2010. The company also highlighted recent product development activities and planned milestones.
Read more on Business Wire via Yahoo! Finance
Posted in Affiliate Programs |
Tags: 2010, Financial, First, Genetics, Quarter, Reports, Results, Seattle |
No Comments »
